Piramal Pharma Solutions, a provider of sterile drug product development and manufacturing services, will invest $25 million to expand its facilities in Lexington, KY.
 
The company will expand capabilities and capacity for commercial aseptic manufacturing, increasing vial filling capability and lyophilization capacity, as well as upgrades to the associated facilities and utilities. 
 
Phase one of the expansion will add a new manufacturing suite including a high speed vial filling machine that provides controlled/safe environment for handling potent materials with automated Vial Washing and Sterilization.  Piramal will also install a new isolator based vial filler in its existing manufacturing suite. Combined, the two fillers will increase the company’s vial filling capabilities by more than five-fold. 
 
Phase two of the expansion will include the installation of two state-of-the-art lyophilizers, which will integrate with the new filler line in the new manufacturing suite with dedicated capacity for both potent and non-potent products
 
Vivek Sharma, chief executive officer of Pharma Solutions, Piramal Enterprises, said, “Since our initial investment the Kentucky site has demonstrated both leadership and growth, and we are pleased to announce this next phase of investment to enhance capability and capacity. We appreciate the active support from the State of Kentucky, the local Government, and most importantly, the community, as we continue our growth plans in Lexington. The expansion in our capacity at Kentucky will help us better serve our customers who are looking for us to deliver solutions that will improve the standard of care.” 
 
Visit Piramal at Table 98